Literature DB >> 15536168

Glomerular and tubular damage in normotensive and hypertensive rats.

Jarle Ofstad1, Bjarne M Iversen.   

Abstract

Tubular cell damage is an important mediator of interstitial fibrosis in chronic renal diseases. Glomerular and tubular damage in genetic hypertension was therefore studied. Tubular and glomerular damage was investigated in 10-, 40-, and 70-wk-old spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) and compared with glomerular capillary pressure (P(GC)) and glomerulosclerosis in superficial (OC) and juxtamedullary (JMC). Tubular vimentin was used as criterion of tubular damage. Variation in tubular diameter was measured during change in perfusion pressure, and ureter ligation was used to demonstrate the relationship between tubular pressure and appearance of vimentin-positive cells. Tubular and glomerular damage was most pronounced in JMC and greater in SHR than in WKY. It was absent in 10-wk-old WKY and significantly higher in JMC of SHR compared with WKY at 70 wk of age. Numbers of vimentin-positive segments were 18 +/- 9 vs. 38 +/- 7% in JMC of 70-wk-old WKY and SHR (P < 0.02), and glomerulosclerosis was seen in 8 +/- 3 vs. 19 +/- 5% of glomeruli in JMC of 70-wk-old WKY and SHR, respectively (P < 0.01). P(GC) was 45 +/- 3 mmHg in JMC of WKY and 57 +/- 3 mmHg in JMC of 70-wk-old SHR (P < 0.001). Tubular diameter variation was greatest in SHR (P < 0.05) during pressure variation. Proteinuria was present only in 40- and 70-wk-old SHR and did not correlate with tissue damage. Tubular and glomerular damage in both strains develops in parallel and may be caused by a common mechanism, which may be glomerular capillary and tubular wall stretch during acute blood pressure variation which is greatest in JMC in SHR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15536168     DOI: 10.1152/ajprenal.00226.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  19 in total

1.  Animal models of regression/progression of kidney disease.

Authors:  Beom Jin Lim; Hai-Chun Yang; Agnes B Fogo
Journal:  Drug Discov Today Dis Models       Date:  2014

2.  Models of chronic kidney disease.

Authors:  Hai-Chun Yang; Yiqin Zuo; Agnes B Fogo
Journal:  Drug Discov Today Dis Models       Date:  2010

3.  Rosuvastatin beneficially alters the glomerular structure of kidneys from spontaneously hypertensive rats (SHRs).

Authors:  Erica Peres de Barros; Angélica Beatriz Garcia-Pinto; Priscilla Yório Machado; Mário José dos Santos Pereira; Jorge José de Carvalho
Journal:  J Mol Histol       Date:  2011-06-14       Impact factor: 2.611

Review 4.  Chronic kidney disease-associated cardiovascular disease: scope and limitations of animal models.

Authors:  Omid Sadeghi-Alavijeh; Mohammad Tadayyon; Ben Caplin
Journal:  Cardiovasc Endocrinol       Date:  2017-11-15

5.  Association of immunosuppressant-induced protein changes in the rat kidney with changes in urine metabolite patterns: a proteo-metabonomic study.

Authors:  Jost Klawitter; Jelena Klawitter; Erich Kushner; Karen Jonscher; Jamie Bendrick-Peart; Dieter Leibfritz; Uwe Christians; Volker Schmitz
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

6.  Motility of the ureter of the spontaneously hypertensive rat.

Authors:  D Rasidovic; S J Bund
Journal:  Ir J Med Sci       Date:  2011-01-12       Impact factor: 1.568

Review 7.  Hypertension Induced Morphological and Physiological Changes in Cells of the Arterial Wall.

Authors:  Patricia Martinez-Quinones; Cameron G McCarthy; Stephanie W Watts; Nicole S Klee; Amel Komic; Fabiano B Calmasini; Fernanda Priviero; Alexander Warner; Yu Chenghao; Camilla F Wenceslau
Journal:  Am J Hypertens       Date:  2018-09-11       Impact factor: 2.689

8.  Sex Differences in Renal Inflammation and Injury in High-Fat Diet-Fed Dahl Salt-Sensitive Rats.

Authors:  Roxanne Fernandes; Hannah Garver; Jack R Harkema; James J Galligan; Gregory D Fink; Hui Xu
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

9.  Hypercholesterolemia Impairs Nonstenotic Kidney Outcomes After Reversal of Experimental Renovascular Hypertension.

Authors:  Dong Sun; Zhi Chen; Alfonso Eirin; Xiang-Yang Zhu; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2016-01-05       Impact factor: 2.689

10.  Treatment with pyrrolidine dithiocarbamate improves proteinuria, oxidative stress, and glomerular hypertension in overload proteinuria.

Authors:  Edilia Tapia; Dolores J Sánchez-González; Omar N Medina-Campos; Virgilia Soto; Carmen Avila-Casado; Claudia M Martínez-Martínez; Richard J Johnson; Bernardo Rodríguez-Iturbe; José Pedraza-Chaverrí; Martha Franco; Laura G Sánchez-Lozada
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.